Navigation Links
Clomipramine & Metabolite

ProductsClomipramine & Metabolite
Company ARUP Laboratories
Item Clomipramine & Metabolite
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Drugs of Abuse Array Cocaine Metabolite Assay
2. Amiodarone & Metabolite
3. Amoxapine & Metabolite, Serum or Plasma
4. Amoxapine & Metabolite, Urine
5. Antabuse Disulfiram (DEDTC Metabolite) Quantitation, Serum or Plasma
6. Antabuse, Disulfiram (DEDTC Metabolite) Quantitation, Urine
7. Bupropion & Metabolite
8. Cocaine & Metabolites Detection
9. Cocaine MetabolitesConfirmation/Quantitation, Meconium
10. Cocaine Metabolite (Benzoylecgonine) Confirmation/Quantitation, Urine
11. Darvon & Metabolite Confirmation/Quantitation, Serum or Plasma
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 4AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 1AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 2AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 3Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 1Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 2Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 3Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 4Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 1Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 2Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 3